Sign Up Today and Learn More About Lygos Stock
Invest in or calculate the value of your shares in Lygos or other pre-IPO companies through EquityZen's platform.
About Lygos Stock
Founded
2010
Headquarters
Berkeley, CA, US
Total Funding
45.0M
Industries
Manufacturing, Science and Engineering, Energy
Founded in 2010, Lygos is providing biotechnology solutions for today’s renewable chemical challenges. They engineer microbes to convert sugars into high-value, industrial chemicals, targeting compounds where biological production is cost-advantaged over petrochemical production.
Lygos Press Mentions
Stay in the know about the latest news on Lygos
Lygos Upgrades Technology Capabilities to Accelerate Microbial Cell Factory Development Timelines
Business Wire • Sep 05, 2019
Lygos Announces Bio-DEM™ Product Qualified at Metric Ton Scale for Sirrus’ Chemilian™ and Forza™ Product Lines
Business Wire • Aug 07, 2019
Lygos Awarded $2 Million Grant to Develop Artificial Intelligence and Machine Learning Technologies to Revive U.S. Biomanufacturing
Business Wire • Jun 03, 2019
Lygos Appoints Photon Rao as Chief Patent Counsel
AP • May 07, 2019
A modern-day David-and-Goliath: How Lygos CEO Eric Steen is tackling the petrochemical industry
Synbiobeta • Apr 12, 2019
Investors in Lygos
Discover investors in Lygos stock and explore their portfolio companies
Lygos Management
Leadership team at Lygos
Founder & Chief Executive Officer
Eric Steen
Chief Patent Counsel
Photon Rao
Join now and verify your accreditation status to gain access to:
- Lygos Current Valuation
- Lygos Stock Price
- Lygos Management
- Available deals in Lygos and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Lygos Cap Table and Funding History by Share Class and Liquidity Preferences
- Lygos Revenue and Financials
- Lygos Highlights
- Lygos Business Model
- Lygos Risk Factors
- Lygos Research Report from SACRA Research
Trading Lygos Stock
How to invest in Lygos stock?
Accredited investors can buy pre-IPO stock in companies like Lygos through EquityZen funds. These investments are made available by existing Lygos shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Lygos stock?
Shareholders can sell their Lygos stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."